1. Home
  2. SLS vs ISTR Comparison

SLS vs ISTR Comparison

Compare SLS & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • ISTR
  • Stock Information
  • Founded
  • SLS 2012
  • ISTR 2006
  • Country
  • SLS United States
  • ISTR United States
  • Employees
  • SLS N/A
  • ISTR N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • ISTR Major Banks
  • Sector
  • SLS Health Care
  • ISTR Finance
  • Exchange
  • SLS Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • SLS 233.7M
  • ISTR 222.8M
  • IPO Year
  • SLS N/A
  • ISTR 2014
  • Fundamental
  • Price
  • SLS $1.93
  • ISTR $22.99
  • Analyst Decision
  • SLS Strong Buy
  • ISTR Buy
  • Analyst Count
  • SLS 1
  • ISTR 1
  • Target Price
  • SLS $7.00
  • ISTR $27.00
  • AVG Volume (30 Days)
  • SLS 2.5M
  • ISTR 36.6K
  • Earning Date
  • SLS 11-12-2025
  • ISTR 10-17-2025
  • Dividend Yield
  • SLS N/A
  • ISTR 1.93%
  • EPS Growth
  • SLS N/A
  • ISTR 46.46
  • EPS
  • SLS N/A
  • ISTR 2.24
  • Revenue
  • SLS N/A
  • ISTR $90,651,000.00
  • Revenue This Year
  • SLS N/A
  • ISTR $11.73
  • Revenue Next Year
  • SLS N/A
  • ISTR $60.34
  • P/E Ratio
  • SLS N/A
  • ISTR $10.20
  • Revenue Growth
  • SLS N/A
  • ISTR 12.41
  • 52 Week Low
  • SLS $0.77
  • ISTR $15.39
  • 52 Week High
  • SLS $2.27
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • SLS 59.08
  • ISTR N/A
  • Support Level
  • SLS $1.81
  • ISTR N/A
  • Resistance Level
  • SLS $1.92
  • ISTR N/A
  • Average True Range (ATR)
  • SLS 0.10
  • ISTR 0.00
  • MACD
  • SLS 0.03
  • ISTR 0.00
  • Stochastic Oscillator
  • SLS 87.67
  • ISTR 0.00

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: